Brief, factual summary in Slovak: The new edition of the journal JAMA contains an overview of peripheral neuropathy, a study on the use of CT angiography to predict first coronary events and a meta-analysis on the effect of SGLT2 inhibitors on renal outcomes. The study showed that SGLT2 inhibitors bring benefits in reducing the risk of kidney complications, even in patients with lower glomerular filtration and higher albuminuria. Furthermore, the need for wider clinical use of SGLT2 inhibitors is discussed in the journal. The article also reports on the trends and prevalence of metabolic syndrome in the US.